Drug Development Process
1 ClinicalTrials.gov Presented by: Suzanne O’Shea Baker & Daniels LLP 317-569-4649 [email protected].
Did you know newsletter n2-2015
Incidence of and Risk Factors for Sudden Cardiac Death in Children with Dilated Cardiomyopathy: A Report from the Pediatric Cardiomyopathy Registry Elfriede.
CTMO Lunch & Learn ClinicalTrials.gov February 24, 2015.
Joshi et al., 2013 Glutamate Activity in ACC Statistical Significance: **p≤0.01 Spectroscopy in Adolescent Males with HF-Autistic Disorder Higher glutamate.
111 Update on Clinical Trials Registration and Results Reporting Requirements Deborah A. Zarin, M.D. ClinicalTrials.gov February 24, 2009.
The NLM Update – Part 1 Expanding into the ‘Adjacent Possible’* *Stuart A. Kauffman Betsy L. Humphreys, MLS, FMLA Acting Director National Library of Medicine.
Current Topics in Human Subjects Research 2012 Sandra L. Alfano, Pharm.D, CIP Research Scientist, GIM Chair, HIC II and IV December 13, 2012.
Everything You Need to Know About Clinical Trials Registration and Results Reporting Requirements
